Spyre Therapeutics, Inc. (SYRE)
104.00
+1.09
(+1.06%)
USD |
NASDAQ |
Nov 13, 16:00
103.98
-0.02
(-0.02%)
Pre-Market: 19:59
Spyre Therapeutics Market Cap : 9.355B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 9.355B |
| November 12, 2026 | 9.257B |
| November 11, 2026 | 9.609B |
| November 10, 2026 | 9.398B |
| November 09, 2026 | 9.805B |
| November 06, 2026 | 9.343B |
| November 05, 2026 | 8.689B |
| November 04, 2026 | 8.909B |
| November 03, 2026 | 8.930B |
| November 02, 2026 | 8.592B |
| October 30, 2026 | 8.686B |
| October 29, 2026 | 8.715B |
| October 28, 2026 | 8.784B |
| October 27, 2026 | 8.722B |
| October 26, 2026 | 8.182B |
| October 23, 2026 | 7.955B |
| October 22, 2026 | 8.131B |
| October 21, 2026 | 8.186B |
| October 20, 2026 | 8.049B |
| October 19, 2026 | 7.461B |
| October 16, 2026 | 7.036B |
| October 15, 2026 | 7.054B |
| October 14, 2026 | 6.924B |
| October 13, 2026 | 7.085B |
| October 12, 2026 | 7.565B |
| Date | Value |
|---|---|
| October 09, 2026 | 7.546B |
| October 08, 2026 | 7.036B |
| October 07, 2026 | 7.120B |
| October 06, 2026 | 7.055B |
| October 05, 2026 | 8.165B |
| October 02, 2026 | 8.207B |
| October 01, 2026 | 7.920B |
| September 30, 2026 | 7.840B |
| September 29, 2026 | 7.461B |
| September 28, 2026 | 7.555B |
| September 25, 2026 | 7.546B |
| September 24, 2026 | 7.670B |
| September 23, 2026 | 7.765B |
| September 22, 2026 | 8.099B |
| September 21, 2026 | 8.105B |
| September 18, 2026 | 7.948B |
| September 17, 2026 | 8.162B |
| September 16, 2026 | 8.029B |
| September 15, 2026 | 8.009B |
| September 14, 2026 | 7.996B |
| September 11, 2026 | 7.979B |
| September 10, 2026 | 7.812B |
| September 09, 2026 | 7.655B |
| September 08, 2026 | 7.995B |
| September 04, 2026 | 7.836B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 521.47B |
| Incyte Corp. | 24.68B |
| SELLAS Life Sciences Group, Inc. | 1.587B |
| Relay Therapeutics, Inc. | 3.971B |
| ACADIA Pharmaceuticals, Inc. | 3.240B |
Market Cap Related Metrics
| PEG Ratio | -0.8116 |
| Price to Book Value | 10.34 |
| Price | 104.00 |
| Earnings Yield | -2.96% |
| PEGY Ratio | -0.8116 |